Literature DB >> 7829225

Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts.

J R Graff1, E R Boghaert, A De Benedetti, D L Tudor, C C Zimmer, S K Chan, S G Zimmer.   

Abstract

Expression of the T24ras oncogene induces malignancy (tumor growth, invasion and metastasis) in cloned rat embryo fibroblasts (CREF T24). In CREF T24, the rate of phosphorylation of eukaryotic translation initiation factor 4E (eIF-4E) is increased, resulting in increased protein synthesis rates. We have recently shown that reducing the protein levels of eIF-4E in CREF T24 (AS4E line) markedly decreases soft-agar colonization, increases tumor latency periods and increases tumor doubling times without significantly altering monolayer growth. In this study, cells with reduced eIF-4E had delayed and reduced invasiveness and decreased experimental metastasis. Furthermore, reduced eIF-4E levels correlated with decreased expression of the metastasis-associated 92-kDa collagenase type-IV and exon-6 variants of the CD44 adhesion molecule [CD44(6v)]. Reduced eIF-4E levels correlated inversely with increased levels of the putative metastasis-suppressor protein nm23. Cell lines established from AS4E tumors and lung metastases exhibited increased levels of eIF-4E protein and protein synthesis rates compared to the AS4E line. Tumor-derived AS4E had the shortened tumor latency periods of CREF T24 but displayed the slow tumor-growth rates of AS4E. Tumor-derived AS4E exhibited the metastatic capacity of CREF T24 controls. Furthermore, tumor- and lung-nodule-derived AS4E expressed levels of CD44 (6v) and the 92-kDa collagenase type IV comparable to CREF T24 and displayed reduced levels of nm23 relative to AS4E. These results demonstrate that eIF-4E is an important effector molecule involved in oncogenic p21ras-induced malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829225     DOI: 10.1002/ijc.2910600221

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

Review 1.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

2.  High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.

Authors:  Kiyotaka Mochizuki; Akihiro Oguro; Takashi Ohtsu; Nahum Sonenberg; Yoshikazu Nakamura
Journal:  RNA       Date:  2005-01       Impact factor: 4.942

3.  eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.

Authors:  Shahram Khosravi; Kevin J Tam; Gholamreza S Ardekani; Magdalena Martinka; Kevin J McElwee; Christopher J Ong
Journal:  J Invest Dermatol       Date:  2015-01-06       Impact factor: 8.551

4.  Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas.

Authors:  S Wang; I B Rosenwald; M J Hutzler; G A Pihan; L Savas; J J Chen; B A Woda
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

Review 5.  Developing anti-neoplastic biotherapeutics against eIF4F.

Authors:  Jutta Steinberger; Jennifer Chu; Rayelle Itoua Maïga; Katia Sleiman; Jerry Pelletier
Journal:  Cell Mol Life Sci       Date:  2016-12-21       Impact factor: 9.261

Review 6.  Therapeutic Opportunities in Eukaryotic Translation.

Authors:  Jennifer Chu; Jerry Pelletier
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

7.  The antiviral drug ribavirin does not mimic the 7-methylguanosine moiety of the mRNA cap structure in vitro.

Authors:  Belinda Westman; Lisa Beeren; Ewa Grudzien; Janusz Stepinski; Remigiusz Worch; Joanna Zuberek; Jacek Jemielity; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads; Thomas Preiss
Journal:  RNA       Date:  2005-08-30       Impact factor: 4.942

8.  In vitro inhibition of translation initiation by N,N'-diarylureas--potential anti-cancer agents.

Authors:  Séverine Denoyelle; Ting Chen; Limo Chen; Yibo Wang; Edvin Klosi; José A Halperin; Bertal H Aktas; Michael Chorev
Journal:  Bioorg Med Chem Lett       Date:  2011-11-16       Impact factor: 2.823

9.  Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.

Authors:  Oshrat Attar-Schneider; Liat Drucker; Maya Gottfried
Journal:  Lab Invest       Date:  2016-08-08       Impact factor: 5.662

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.